The 2022 World Diabetes Congress, organized by the International Diabetes Federation (IDF), was smoothly held in December at the Lisbon Convention Center in Portugal, providing a professional knowledge exchange forum for healthcare professionals, advocates and diabetes patients worldwide through a combination of online and offline formats. This time, Gan & Lee Pharmaceuticals appeared at the conference as an exhibitor, and as the only insulin company exhibiting offline at the conference, it drew wide attention from industry experts. In addition, Gan & Lee Pharmaceuticals conducted several rounds of academic exchanges and interactions with global experts in the field of diabetes, and the event was a complete success.